HWAM
IMCR icon

Hennion & Walsh Asset Management’s Immunocore IMCR Stock Holding History

Hennion & Walsh Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
48,324
+1,197
+3% +$35.4K 0.04% 455
2026
Q1 		$1.42M Sell
47,127
-1,458
-3% -$47.2K 0.05% 431
2025
Q4 		$1.69M Sell
48,585
-14,077
-22% -$497K 0.06% 395
2025
Q3 		$2.28M Sell
62,662
-4,118
-6% -$140K 0.08% 307
2025
Q2 		$2.1M Buy
66,780
+4,225
+7% +$131K 0.08% 308
2025
Q1 		$1.86M Buy
62,555
+12,947
+26% +$388K 0.08% 290
2024
Q4 		$1.46M Buy
49,608
+27,598
+125% +$872K 0.07% 367
2024
Q3 		$685K Sell
22,010
-612
-3% -$22.3K 0.03% 540
2024
Q2 		$767K Buy
22,622
+1,390
+7% +$70.9K 0.04% 485
2024
Q1 		$1.38M Buy
21,232
+8,848
+71% +$607K 0.07% 340
2023
Q4 		$846K Buy
+12,384
New +$644K 0.05% 444

Other funds holding IMCR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Hennion & Walsh Asset Management's IMCR Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Immunocore (IMCR) stake by 2.5% in Q2 2026, buying an estimated $35.4K and bringing the position to 48,324 shares worth $1.53M. The position accounts for 0.04% of the portfolio, ranked #455.

Hennion & Walsh Asset Management first reported a position in IMCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.28M in Q3 2025. 15 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Hennion & Walsh Asset Management held 48,324 shares of Immunocore worth $1.53M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 1,197 Immunocore shares in Q2 2026, an estimated $35.4K.
  • Immunocore made up 0.04% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #455 holding.
  • Hennion & Walsh Asset Management first reported a position in Immunocore in Q4 2023 and has held it in 11 quarters since.
  • Hennion & Walsh Asset Management's Immunocore position peaked at $2.28M in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.